Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.
Conclusion: Eszopiclone, zolpidem, and suvorexant may improve short-term global and sleep outcomes for adults with insomnia disorder, but the comparative effectiveness and long-term efficacy of pharmacotherapies for insomnia are not known. Pharmacotherapies for insomnia may cause cognitive and behavioral changes and may be associated with infrequent but serious harms.
Primary Funding Source: Agency for Healthcare Research and Quality.
PMID: 27136278 [PubMed - as supplied by publisher]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL Tags: Ann Intern Med Source Type: research
More News: Ambien | Databases & Libraries | Dementia | Eszopiclone | Insomnia | Internal Medicine | Lunesta | Melatonin | Orthopaedics | PET Scan | Sleep Disorders | Sleep Medicine | Study | Women